BioSpecifics Technologies Corporation (BSTC)
Add to Watchlists Create an Alert
15.80
-0.07 -0.44%
NASDAQ
May 24, 5:01PM
BATS Real time
Currency in USD
BioSpecifics Technologies Corporation Revenue Quarterly YoY Growth:
53.86% for March 31, 2013BioSpecifics Technologies Corporation Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 53.86% |
| Dec. 31, 2012 | 34.49% |
| Sept. 30, 2012 | 27.42% |
| June 30, 2012 | -48.06% |
| March 31, 2012 | 39.30% |
| Dec. 31, 2011 | 128.1% |
| Sept. 30, 2011 | 91.36% |
| June 30, 2011 | 486.0% |
| March 31, 2011 | -30.17% |
| Dec. 31, 2010 | 51.62% |
| Sept. 30, 2010 | 20.03% |
| June 30, 2010 | -30.03% |
| March 31, 2010 | 674.2% |
| Dec. 31, 2009 | -89.56% |
| Sept. 30, 2009 | 139.5% |
| June 30, 2009 | 181.2% |
| March 31, 2009 | -14.39% |
| Dec. 31, 2008 | 1644% |
| Sept. 30, 2008 | -5.44% |
| June 30, 2008 | 17.36% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Jan. 31, 2003 | Go Pro |
| Oct. 31, 2002 | Go Pro |
| July 31, 2002 | Go Pro |
| April 30, 2002 | Go Pro |
| Jan. 31, 2002 | Go Pro |
| Oct. 31, 2001 | Go Pro |
| July 31, 2001 | Go Pro |
| April 30, 2001 | Go Pro |
| Jan. 31, 2001 | Go Pro |
| Oct. 31, 2000 | Go Pro |
| July 31, 2000 | Go Pro |
| April 30, 2000 | Go Pro |
| Jan. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
BSTC Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Auxilium Pharmaceuticals | -10.10% |
| Progenics Pharmaceuticals | 304.4% |
| Sangamo BioSciences | 88.12% |
BSTC Revenue Quarterly YoY Growth Rankings
| Overall |
92nd percentile 582 of 8009 |
| Sector |
85th percentile 97 of 687 in Healthcare |
| Industry |
82nd percentile 44 of 248 in Biotechnology |
BSTC Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -89.56% | Dec 2009 |
| Maximum | 1644% | Dec 2008 |
| Average | 168.5% |
